We report the generation of human induced pluripotent stem cells (hiPSCs) from dermal fibroblasts of a female patient carrier of the two compound heterozygous mutations c.568 CNT p.R190W (maternal allele), and c.1781 GNA p.R594Q (paternal allele) on the KCNQ1 gene, causing Jervell and Lange-Nielsen Syndrome (JLNS) . To obtain hiPSCs, we used the classical approach of the four retroviruses each encoding for a reprogramming factor OCT4, SOX2, KLF4, cMYC. The obtained hiPSC clones display pluripotent stem cell characteristics, and differentiate into spontaneously beating cardiomyocytes (hiPSC-CMs).
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Resource utility
It has been proven that iPSCs and iPSC-CMs can be efficiently used to model LQTS, and test targeted therapies Mura et al., 2017; Rocchetti et al., 2017) . The PSMi002-A cell line can be used for: 1) modelling of JLNS; 2) targeted drug testing.
Resource details
The PSMi002-A line was generated by reprogramming of dermal fibroblasts isolated from skin biopsy of a 10 years old girl affected by Jervell and Lange-Nielsen Syndrome (JLNS). JLNS is a recessive form of Long QT Syndrome associated with bilateral hearing loss, marked prolongation of the QT interval at the surface ECG, and a propensity for life-threatening cardiac arrhythmias and sudden cardiac death (Jervell and Lange-Nielsen, 1957) . The enrolled patient has a severe, bilateral sensorineural hearing loss, a significantly prolonged QTc (QT corrected for heart rate of 578 ms), and experienced several syncopal episodes since age 2. At 7 years the diagnosis of JLNS was performed, beta-blocker therapy was started and no other cardiac events occurred. The patient carries two compound heterozygous mutations on the KCNQ1 gene: the c.568 C/T on the maternal allele leads to the substitution of the arginine in position 190 with tryptophan; the c.1781 G/A on the paternal allele leads to the substitution of the arginine in position 594 with a glutamine.
Fibroblasts were reprogrammed by retroviral infection of OCT4, SOX2, KLF4 and c-MYC. The obtained hiPSCs were maintained on feeders, retaining ES-like morphology and pluripotent features up to passage 50. Both fibroblasts and hiPSCs present the disease causing mutations on the KCNQ1 gene, as proved by DNA sequencing (Fig. 1A . The KCNQ1 coding sequence -CDS-used as a reference is the NCBI sequence NM_000218.2) and an identical DNA profile at seven polymorphic loci, as shown by Short tandem Repeat (STR) analysis (submitted in archive with journal). Moreover, the DNA karyotyping revealed normal female karyotype (46, XX) (Fig. 1B) . The PSMi002-A uniformly expresses the human ES surface antigens Tumor Related Antigen-1-60 and -1-81 (TRA-1-60 and TRA-1-81), Stage Specific Embryonic Antigen-3 and -4 (SSEA-3, SSEA-4), and shows alkaline phosphatase (AP) activity (Fig. 1C) . Likewise, it expresses the pluripotent markers NANOG, OCT4, SOX2 (Fig. 1C and  D) , REX1, GDF3, ESG1, DPPA2, DPPA4 and NODAL (Fig. 1D) , and shows OCT4 promoter demethylation (Fig. 1E , open circles indicate unmethylated CpG dinucleotides, while closed circles indicate methylated CpGs). RT-PCR analysis in Fig. 1F shows no expression of the four viral transgenes (Tg) in naïve fibroblasts (HDF), clear expression of Tg OCT4, SOX2, KLF4 and cMYC in fibroblasts five days after transduction (OSKM) and silencing of the four Tg in the PSMi002-A.
As expected, PSMi002-A spontaneously forms embryoid bodies (EBs) able to differentiate into cells belonging to the three germ layers: endoderm, mesoderm and ectoderm (Fig. 1G) . Most importantly, we have successfully differentiated this JLNS cell line into cardiomyocytes displaying spontaneous beating activity, and expressing the sarcomeric proteins alpha-actinin (α-SA) and troponin T (TnT) (Fig. 1H , the insets show areas of cross-striation). We also verified the absence fo mycoplasma contamination in our PSMi002-A line (Fig. 1I ).
Materials and methods

Generation and clonal expansion of hiPSCs
The detailed protocol is provided as Supplemental methods. Briefly, skin fibroblasts were reprogrammed using four retroviral vectors expressing OCT4, SOX2, KLF4 and cMYC. Clonal selection of fully reprogrammed cells was performed manually under sterile conditions and using an EVOS XL Core Imaging System (ThermoFisher), by picking individual clones morphologically similar to embryonic stem cells. Colonies were cut, harvested with a pipette, individually placed into a separate cell culture well and expanded (Table 1) .
Mutation analysis
Genomic DNA was extracted with QIAamp DNA Blood Mini kit (Qiagen). KCNQ1 gene sequence was amplified with the GoTaq G2 DNA polymerase (Promega) (see Table 2 for primer sequences). The resulting amplicons were purified and sequenced (Lightrun service -GATC Biotech AG -Germany).
STR analysis
STR analysis was carried out using PowerPlex® CS7 System (Promega) kit, following the manufacturer's protocol. Fragments were run on a 3130xl capillary sequencer (Applied Biosystems). Genotypes were assigned using GeneMarker software (SoftGenetics).
Karyotyping
hiPSCs were blocked at metaphase by exposition to 10 μg/ml demecolcine solution (Sigma Aldrich) for 3 h. Karyotyping was performed using 300 G-banding chromosome analysis. Immunocytochemistry hiPSCs and their derivatives were grown on glass coverslips, and then fixed for 15 min in 4% paraformaldehyde (Affimetrix USB), permeabilized with 0.1% Triton X-100 (Sigma Aldrich) for 5 min, and blocked in 1% bovine serum albumin (BSA, Sigma Aldrich) for 1 h at room temperature (RT). Then they were incubated for 1 h at RT with the primary antibody (Table 2) diluted in blocking solution, washed three times, and incubated for 1 h at RT with an appropriate secondary antibody (Table 2) . Finally, the cells were stained with 1 μg/ml of Hoechst 33258 (Sigma Aldrich). Images were acquired using the Carl Zeiss fluorescence microscope Observer.Z1 equipped with the Apotome system and AxioVision 6.0 software (Zeiss GmbH, Gottingen, Germany).
AP colorimetric assay
AP was detected by using the Alkaline Phosphatase Staining kit (00-0009 Stemgent).
RT-PCR
Total RNA was purified using TRIzol (ThermoFisher Scientific). cDNA was synthesized using the Superscript II Reverse Transcriptase (ThermoFisher). RT-PCR was performed with the GoTaq G2 DNA polymerase (Promega) and primers in Table 2 .
OCT4 promoter demethylation analysis
Genomic DNA was treated with the EZ DNA methylation kit (Zymo Research, Orange, CA, USA). The promoter region of the human OCT4 gene was amplified using Amplitaq gold 360 (Applied Biosystems). The PCR products were sequenced using Pyrosequencing PSQ96 HS System (Biotage, Uppsala, Sweden). The methylation status of each locus was analyzed using PyroQ-CpG software (Qiagen).
EB formation
hiPSCs were grown for 7 days in non-adherent conditions in a modified iPS medium deprived of bFGF and containing 20% FBS instead of KO-SR. Forming EBs were then transferred to gelatin-coated dishes to allow differentiation in adhesion for additional 7 days. Finally, the cells were processed for immunostaining of the three germ layers as described above.
Cardiac differentiation
Cardiac differentiation was induced using the PSC Cardiomyocyte Differentiation Kit (ThermoFisher).
Mycoplasma test
For the detection of mycoplasma in cell culture we used the EZ-PCR Mycoplasma Test Kit (Biological Industries). Embryoid body formation The EBs expressed neuronal class tubulin beta III (Tuj) and microtubule-associated protein (MAP) (ectoderm); smooth muscle actin (SMA) and troponin I (mesoderm); alpha fetoprotein (AFP) (endoderm). 
Differentiation into cardiomyocytes
The iPSC-derived cardiomyocytes expressed the cardiac sarcomeric proteins alpha-sarcomeric actinin (α-SA) and troponin T (TnT) Fig. 1 
